Codeine-Associated Secondary Adrenal Insufficiency: A Case Report
- 1General Medicine, Kingston Hospital, London, GBR
- 2Internal Medicine, Dr. B.R. Ambedkar Medical College, Bangalore, IND
- 3Diabetes and Endocrinology, Surrey and Sussex Healthcare NHS Trust, Surrey, GBR
Abstract
We report the case of a 47-year-old woman who presented with a two-month history of significant lethargy, dizziness, and weakness. Blood tests showed a significantly low 9:00 am cortisol level of 52 nmol/L (normal: >275 nmol/L), an abnormal Synacthen test, and low adrenocorticotropic hormone (ACTH) levels. The remaining pituitary function tests and MRI of the pituitary and hypothalamus were normal. Interestingly, she had been taking the maximum licensed dose of codeine for back pain for 12 weeks before the blood tests. Adrenal insufficiency was thought to be induced by codeine, and the medication was stopped immediately. Her symptoms resolved spontaneously without steroid replacement, and repeat investigations six months later showed full recovery of adrenal function. Opioids suppress cortisol secretion, mainly through negative feedback on the hypothalamus and pituitary gland. The literature suggests that opioids also interact with other endocrine functions. Although hypogonadotropic hypogonadism is the most reported endocrine effect, opioids also exert inhibitory effects on the corticotropic axis.
Related
- Pembrolizumab-Associated Adrenal Insufficiency Presenting as Adrenal Crisis: A Case Report.
- Steroid Withdrawal Syndrome and Adrenal Insufficiency Following Unsupervised Steroid Use: A Case Report.
- Case Report: Long-lasting adrenal insufficiency following successful osilodrostat therapy with subsequent recurrence of Cushing’s syndrome
- Long-term cyclic ectopic adrenocorticotropic hormone syndrome with extreme fluctuations and adrenal insufficiency
- Primary Adrenal Insufficiency in a Patient with Mosaic Klinefelter Syndrome
BibTeX
@article{varghese2026codeineassociated,
title = {{Codeine-Associated Secondary Adrenal Insufficiency: A Case Report}},
author = {Eleesha A Varghese and Nathan T Zachariah and Sunil Zachariah},
journal = {Cureus},
year = {2026},
month = oct,
doi = {10.7759/cureus.118882},
url = {https://europepmc.org/article/PMC/PMC13723050},
note = {CC BY},
}
RIS
TY - JOUR
TI - Codeine-Associated Secondary Adrenal Insufficiency: A Case Report
AU - Eleesha A Varghese
AU - Nathan T Zachariah
AU - Sunil Zachariah
PY - 2026
DA - 2026/10/31
JO - Cureus
DO - 10.7759/cureus.118882
UR - https://europepmc.org/article/PMC/PMC13723050
AB - We report the case of a 47-year-old woman who presented with a two-month history of significant lethargy, dizziness, and weakness. Blood tests showed a significantly low 9:00 am cortisol level of 52 nmol/L (normal: >275 nmol/L), an abnormal Synacthen test, and low adrenocorticotropic hormone (ACTH) levels. The remaining pituitary function tests and MRI of the pituitary and hypothalamus were normal. Interestingly, she had been taking the maximum licensed dose of codeine for back pain for 12 weeks before the blood tests. Adrenal insufficiency was thought to be induced by codeine, and the medication was stopped immediately. Her symptoms resolved spontaneously without steroid replacement, and repeat investigations six months later showed full recovery of adrenal function. Opioids suppress cortisol secretion, mainly through negative feedback on the hypothalamus and pituitary gland. The literature suggests that opioids also interact with other endocrine functions. Although hypogonadotropic hypogonadism is the most reported endocrine effect, opioids also exert inhibitory effects on the corticotropic axis.
SN - 2168-8184
ER -